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OBJECTIVE—Glucagon-like peptide (GLP)-1 inhibits food in-
take, acting both in the periphery and within the central nervous
system. It is unclear if gut-derived GLP-1 can enter the brain, or
whether GLP-1 from preproglucagon (PPG) cells in the lower
brainstem is required to activate central GLP-1 receptors. Brain-
stem PPG neurons, however, have been poorly characterized, due
to the difﬁculties in identifying these cells while viable. This study
provides data on the electrical properties of brainstem PPG cells
and their regulation by orexigenic and anorexigenic peptides.
RESEARCH DESIGN AND METHODS—Transgenic mice ex-
pressing Venus under control of the PPG promoter were used to
identify PPG neurons in vitro in brainstem slice preparations for
electrophysiological recordings.
RESULTS—The majority of PPG neurons were spontaneously
active. Further electrical and molecular characterization re-
vealed that GLP-1 receptor activation had no pre- or postsynaptic
effect and that PPG neurons lack GLP-1 receptors. Similarly, they
were unresponsive to PYY and ghrelin. In contrast, leptin rapidly
and reversibly depolarized these neurons. Responses to electri-
cal stimulation of the solitary tract suggest that PPG cells are
mostly second-order neurons, receiving direct input from vagal
afferent ﬁbers. Both evoked and spontaneous excitatory postsyn-
aptic currents were predominantly glutamatergic.
CONCLUSIONS—The study introduces PPG-promoter-Venus
transgenic mice as a viable and important tool to study brainstem
PPG cells. PPG neuron activity is directly modulated by leptin
but was unaffected by other satiety or hunger peptides. Direct
synaptic input from the solitary tract suggests that peripheral
signals (including GLP-1) could modulate PPG cells via vagal
afferents. Diabetes 59:1890–1898, 2010
G
lucagon-like peptide 1 (GLP-1) is an enteroen-
docrine hormone released postprandially from
L-cells in the gut that stimulates insulin secre-
tion and inhibits glucagon secretion. It also
inhibits food and water intake and delays gastric empty-
ing. Appetite-suppressive effects can be elicited by both
peripheral and central application of GLP-1, raising ques-
tions about whether brain GLP-1 receptors respond pri-
marily to gut-derived GLP-1 or to GLP-1 released within
the central nervous system.
Whether GLP-1 levels even rise sufﬁciently after a meal
to modulate central GLP-1 receptors remains controver-
sial. Whereas Orskov et al. (1) argue that only GLP-1
receptors located in the area postrema (AP) and the
subfornical area are accessible to peripheral GLP-1, Kastin
et al. (2) claim that GLP-1 can readily diffuse across the
blood-brain barrier. In any case, GLP-1 is rapidly inacti-
vated in the circulation, with a half-life of 2 min. This
might suggest that centrally active GLP-1 originates
from the previously described subset of caudal nucleus
tractus solitarius (NTS) neurons, which produce GLP-1
by posttranslational processing of preproglucagon
(PPG) (3–5).
Relatively little is known about these NTS PPG neurons.
They project to various forebrain sites, including hypotha-
lamic nuclei and the amygdala, as well as locally within the
lower brainstem (3–5). Within the hypothalamus, the dens-
est innervation is observed in the paraventricular nucleus
and the ventral part of the dorsomedial nucleus (3),
regions that also exhibit strong expression of GLP-1 re-
ceptors (5).
The NTS receives input from sensory vagal neurons and
is activated by gastrointestinal satiety signals such as
gastric distension and luminal nutrients. c-Fos immunore-
activity has been observed in PPG neurons of the NTS
after balloon gastric distension, suggesting that satiety
stimuli can result in the activation of central GLP-1 path-
ways (6). In support of this hypothesis, peripheral admin-
istration of leptin induced c-Fos in NTS cells staining
positive for PPG (7) and central application of leptin
increased expression of preproglucagon in the NTS (8). It
has also been reported that central administration of
exendin (9–39), a GLP-1 receptor antagonist, strongly
attenuated the reduction in food intake and body weight
observed after intraventricular injection of leptin in rats
(9). It therefore seems likely that PPG neurons are central
to the integration of diverse satiety signals at the level of
the NTS. This might include peptide YY (PYY3–36), which is
co-released with GLP-1 from L-cells and has additive
effects on food intake with GLP-1 (10), and ghrelin, which
is released as a hunger peptide from the stomach and has
been shown to attenuate the effects of GLP-1 on food
intake (11).
At present, it is not clear whether there is a direct link
between the action of peripheral GLP-1 and the activity of
NTS PPG neurons. Instillation of nutrients into the duode-
num, which would be expected to stimulate release of
endogenous GLP-1, did not induce c-Fos in NTS PPG
neurons (12). However, intravenous injection of ex-
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a region containing a high density of GLP-1 receptors in
catecholaminergic neurons (13). Based on these ﬁndings,
Yamamoto et al. (13) speculated that PPG neurons in the
NTS would receive input from these catecholaminergic AP
cells and thus link peripheral GLP-1 to the release of GLP-1
from PPG cells, with downstream effects on central GLP-1
receptors within the hypothalamus and brainstem. It is
also possible that PPG cells might send dendrites into the
AP and outside the blood-brain barrier or that peripheral
activation of GLP-1 receptors might modulate vagal affer-
ent activity, which is relayed to the PPG cells via the
solitary tract (14).
To date, the electrical properties and connectivity of the
NTS PPG neurons remain largely uncharacterized because
it has been virtually impossible to identify these neurons in
brain slice preparations. Here we have used transgenic
mice expressing the yellow ﬂuorescent protein Venus
under the control of the preproglucagon promoter (15) to
identify this cell population and to characterize their
electrical behavior, connectivity, and responsiveness to
peptides implicated in the modulation of feeding behavior.
RESEARCH DESIGN AND METHODS
Transgenic animals. Transgenic mice were used that expressed a modiﬁed
yellow ﬂuorescent protein (YFP-Venus) under the control of the preprogluca-
gon promoter (15). Two founder strains, mGLU-V23-124 and mGLU-V50-144,
created using mouse bacterial artiﬁcial chromosomes (BACs), were used
interchangeably, since we observed no difference in the pattern of YFP
expression in the brainstem (15). Animals were bred as heterozygotes on a
C57/Bl6 background and were genotyped as described previously (15) before
experimental use. All experiments were carried out in accordance with the U.K.
Animals (Scientiﬁc Procedures) Act, 1986, with appropriate ethical approval.
Histology. Mice were anesthetized with halothane and transcardially per-
fused with ice-cold heparinized saline followed by ice-cold 4% paraformalde-
hyde in phosphate buffer. The brain was removed and postﬁxed with 4%
paraformaldehyde at 4°C overnight. Brains were cryoprotected with 30% sucrose
in PBS, and 30-m coronal brainstem sections were cut using a cryostat.
For immunoﬂuorescence visualization of cholinergic cells, sections were
incubated for 30 min in block solution (10% rabbit serum, 1% BSA, 0.1% triton
X-100 in PBS), followed by overnight incubation with a polyclonal goat
antibody against choline acetyltransferase (anti-ChAT, 1:1500; Chemicon) in
block solution at 4°C. After ﬁve washes in PBS, the sections were incubated
in the dark for2ha troom temperature in a rabbit anti-goat IgG CY-3
conjugate (1:500; Sigma). Sections were mounted and cover-slipped with
Vectashield. An equivalent protocol was used to visualize catecholaminergic
cells with a polyclonal rabbit antibody against tyrosine-hydroxylase (anti-TH,
1:500; Santa Cruz). Block solution contained 10% sheep serum, and the
secondary antibody was a sheep anti-rabbit IgG CY-3 conjugate (1:500; Sigma).
Mounted sections were analyzed under a Nikon upright microscope with
epiﬂuorescence to visualize ﬂuorescence of YFP and CY-3.
Single-cell RT-PCR. Samples for RT-PCR and single-cell RT-PCR were
harvested and ampliﬁed as described previously (16), using primers listed in
Table 1. As negative controls for single-cell RT-PCR, reactions were routinely
performed with H2O instead of DNA sample, with solution from pipettes that
were inserted into the slice without recording from a cell and with samples
that were not reverse-transcribed. For positive controls, PCRs were per-
formed on a 1:100–1:1,000 dilution of brainstem cDNA. PCR products were
veriﬁed by direct sequencing (MWG Biotech, London, U.K.).
Electrophysiology. Coronal (200 m) or horizontal (250 m) brainstem
slices were obtained from adult (8 weeks) transgenic mice of either sex after
halothane anesthesia and dissection in ice-cold low Na
 solution containing
(in mmol/l): 200 sucrose, 2.5 KCl, 28 NaHCO3, 1.25 NaH2PO4, 3 pyruvate, 7
MgCl2, 0.5 CaCl2, and 7 glucose (pH 7.4). After recovery at 34°C for 30 min in
a solution containing (in mmol/l) 118 NaCl, 3 KCl, 25 NaHCO3, 1.2 NaH2PO4,
7 MgCl2, 0.5 CaCl2, and 2.5 glucose (pH 7.4), slices were kept at 34°C in
artiﬁcial cerebrospinal ﬂuid (ACSF) of the following composition (in mmol/l):
118 NaCl, 3 KCl, 25 NaHCO3, 1 MgCl2, 2 CaCl2, and 10 glucose (pH 7.4). Patch
pipettes were pulled from thin-walled borosilicate capillaries (3–6 M; Clark
Electromedical Instruments, Pangbourne, U.K.) with a horizontal puller (Zeitz,
Germany). Electrodes were ﬁlled with (in mmol/l) 120 K-gluconate, 5 HEPES,
5 BAPTA, 1 NaCl, 1 MgCl2, 1 CaCl2,a n d2K 2ATP, pH 7.2. For perforated-patch
whole-cell recording, solubilized amphotericin B (Sigma) was added to the
pipette solution (ﬁnal concentration 137.5 g/ml).
Recordings were carried out in ACSF at 28–32°C. Experimental solutions
were constantly bubbled with 95% O2/5% CO2. Most drugs were directly added
to the ACSF. 6,7-Dinitroquinoxaline-2,3-dione (DNQX) was prepared as a 20
mmol/l stock solution in DMSO. Tetrodotoxin was prepared as a 1 mmol/l
stock solution in Na-citrate buffer. The recording chamber (volume 2 ml) was
perfused with ACSF at a rate of 4–5 ml/min. Drugs were applied either within
the ACSF perfusing the bath (4–5 ml/min) or locally via pressure ejection from
a glass pipette (opening diameter 5–10 m) facing the recorded cell positioned
at a distance of 100 m. Exendin-4 and PYY3–36 were obtained from Tocris
Bioscience (Bristol, U.K.). Ghrelin and GLP-17–37 were obtained from Sigma
(Gillingham, U.K.). Leptin was a kind gift from Novo Nordisk AS (Copenhagen,
Denmark).
Recordings were performed in both voltage-clamp and current-clamp mode
using an EPC-9 ampliﬁer and Pulse/Pulseﬁt software (Heka Elektronik,
Lambrecht, Germany). Currents or membrane potentials were ﬁltered at 1 kHz
and digitized at 4 kHz. Membrane resistance was monitored with 200 ms
current or voltage pulses every 20 s. Current-voltage relationships were
obtained either by analyzing hyperpolarizing and depolarizing 200-ms voltage
or current steps, or by holding the cell at 20 mV for a minimum of 30 s and
then applying a voltage ramp from 20 to 120 mV over 700 ms.
For analysis of ﬁring frequency, membrane potential, input resistance, and
spontaneous excitatory postsynaptic current frequency, the mean value over
3 min before addition of the drug and the mean over the last 3 min before drug
removal were compared. For leptin and glutamate, which were washed off
quickly to ascertain reversibility, peak responses were compared to the mean
before drug application.
Solitary tract stimulation. A concentric bipolar electrode (150 m diame-
ter) was placed in the solitary tract of horizontal brainstem slices 2–4 mm
away from the ﬂuorescent cell population. Either single shocks (every 10 s) or
bursts of ﬁve shocks (50 Hz; every 20 s) were delivered from a stimulus
isolator (DS2A; Digitimer) driven by the EPC-9 ampliﬁer. Each stimulus had a
duration of 20 s and an amplitude of 40–70 V. Amplitude was increased using
single stimuli during individual recordings until a further increase in stimulus
amplitude had no further effect on excitatory post synaptic current (EPSC)
amplitude. Latency was determined as the delay between the onset of the
stimulus artifact and the onset of the EPSC, as described by Doyle and
Andresen (17). Synaptic jitter was determined as the standard deviation of the
latency for 20 successive single shocks at 0.1 Hz.
Statistical analysis. Data are given as mean  1 SEM. Statistical signiﬁcance
was tested using one-way ANOVA followed by the post hoc Tukey’s test,
unless stated otherwise. P values of 0.05 and 0.01 were taken to indicate
that the data were signiﬁcantly different.
RESULTS
Electrical properties of NTS preproglucagon neu-
rons. PPG neurons in acute brainstem slices were readily
identiﬁable by their Venus ﬂuorescence. The majority of
TABLE 1
PCR primers
Primer PPG GLP-1 receptor Y2 receptor
Outer forward primer ATGAAGACCGTTTACATCGTGGC TCAGAGACGGTGCAGAAATG TGATCCGGAGCCGGAGCTCAT
Outer reverse primer CTGGTGGCAAGGTTATCGAGA GCAAACAGGTTCAGGTGGAT AGGCGTGGAGGGGTAGCCAG
Inner forward ACCAAGAGGAACCGGAAC CAACCGGACCTTTGATGACT CCAACCTGGCTGTGGCGGAT
Inner reverse primer CCAAGTTCCTCAGCTATGGCG CAAGGCGGAGAAAGAAAGTG TCCCCAGGCCACTTCTCGGT
Outer product size (bp) 492 458 750
Inner product size (bp) 186 292 361
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caudal NTS, although additional cell bodies were located
further ventrally, e.g., in the reticular area. Venus-positive
cells had no clear distinguishing morphological features,
and their distribution overlapped with various NTS neuron
populations. They were distinct both from ChAT-positive
cells in the dorsal vagal motor nucleus (DMNX; Fig. 1A)
and from tyrosine hydroxylase (TH)-positive cells in the
NTS—a population that includes adrenergic, noradrener-
gic, and dopaminergic neurons (Fig. 1B).
Electrophysiological recordings were established from
ﬂuorescent cells in the NTS under differential interference
contrast (DIC) optics (Fig. 1C), and cytoplasm was har-
vested at the end of the recordings and subjected to
single-cell RT-PCR for preproglucagon. Eight out of eight
ﬂuorescent cells were positive for preproglucagon and
nine out of nine control cells were negative, verifying both
the correct targeting of the transgene and that preproglu-
cagon is still transcribed in PPG cells expressing Venus.
In perforated patch recordings, it was evident soon after
sealing the electrode onto an individual cell that the
intrinsic electrical activity of PPG neurons could be di-
vided into three types: regular ﬁring, silent, and burst ﬁring
(Fig. 1D). These phenotypes persisted under stable perfo-
rated-patch conditions. Of 135 recorded neurons, the
majority (n 	 99) were spontaneously active with a mean
ﬁring frequency of 1.9  0.2 Hz. These neurons exhibited
a resting membrane potential of 51  1 mV (Fig. 1D and
E), with an average input resistance of 1.05  0.03 G and
capacitance of 28  1 pF. Another 11 cells were electri-
cally silent, with a resting potential of 55  2 mV, an
input resistance of 0.84  0.09 G, and a capacitance of
27  3 pF (Fig. 1D and F). Action potentials could be
elicited in these cells by current injections of 14  1p A
(n 	 9). The remaining 25 neurons showed burst-ﬁring
activity, with spontaneous ﬂuctuations of the membrane
potential by almost 20 mV (Fig. 1D and E) that persisted in
0.5 mol/l tetrodotoxin (n 	 5). These cells had a whole-
cell capacitance of 21  1 pF. In all three cell types,
injection of hyperpolarizing current pulses (200 ms)
caused a delay of 1 s before the return of spontaneous
activity (Fig. 1F), indicating that PPG neurons express
A-type K
 currents. All further experiments for this study
were performed on the spontaneously active cell
population.
Synaptic inputs on PPG neurons. The location of PPG
neurons in the NTS, a region with an intact blood-brain
barrier, suggests that these cells would be predominantly
modulated by synaptic inputs. To investigate excitatory
synaptic inputs onto PPG neurons, cells were held at 70
mV in standard whole-cell recordings, under which condi-
tions EPSCs were observed as inward currents. Spontane-
ous EPSCs (sEPSCs) occurred at a frequency of 3.0  0.5
Hz with an amplitude of 23  2p A( n 	 21) and were
largely glutamatergic, as demonstrated by their inhibition
by kynurenic acid (1 mmol/l) or DNQX (10 mol/l; Fig. 2A
and B). In support of the idea that PPG neurons receive
direct glutamatergic input, glutamate (0.1 mmol/l) trig-
gered membrane depolarization and a reduction in the
membrane resistance. Both actions were reversed by
DNQX (20 mol/l), indicating the involvement of non-
NMDA type glutamate receptors (Fig. 2C and D).
One potential source of excitatory glutamatergic inputs
are vagal sensory neurons. Previous studies in horizontal
brainstem slices have shown that catecholaminergic NTS
neurons receive direct monosynaptic input from afferent
vagal ﬁbers in the solitary tract (18–20). We therefore used
this recording conﬁguration to examine whether PPG
neurons are also responsive to solitary tract stimulation.
Tract stimulation reliably evoked EPSCs in PPG neurons
with a mean latency of 3.2  0.3 ms and a mean peak
amplitude of 126  17 pA (n 	 14) (Fig. 3A and B).
Further assessment of whether the observed responses
were monosynaptic or polysynaptic was performed by
examining their failure rate, latency, and jitter (the vari-
ability of the latency). Of the cells, 11 of 14 had a failure
rate of 5%, and the majority of cells displayed a jitter of
300 s, suggesting that the responses are predominantly,
but not entirely, explained by monosynaptic connections.
DNQX (10 mol/l) completely blocked EPSCs evoked by
tract stimulation in all cells tested (n 	 7), and kynurenic
acid (1 mmol/l) reduced their amplitude by 58% (n 	 3;
Fig. 3C and D). In 10 of 14 cells, the EPSC amplitude
became progressively smaller in response to a burst of ﬁve
shocks at 50 Hz (Fig. 3A, Ci, and Cii). These results suggest
that the majority of PPG cells receive direct synaptic input
from the solitary tract (and are thus second-order neu-
rons) and that both the direct and indirect excitatory
inputs are glutamatergic.
Effects of gut hormones on PPG neurons. GLP-17–37
(100–200 nmol/l) had no effect on the resting membrane
potential, membrane resistance, or ﬁring frequency of PPG
cells (n 	 6; Fig. 4A and B) and did not affect the current
response to voltage ramps between 20 and 120 mV.
Similarly, the stable GLP-1 analog exendin-4 (100 nmol/l)
failed to alter the membrane potential, membrane resis-
tance, or ﬁring frequency of these cells (n 	 5). These
ﬁndings suggested that NTS PPG neurons do not express
functional GLP-1 receptors. This conclusion was further
supported by single-cell RT-PCR analysis of 12 cells from
which cytoplasm was harvested at the end of the record-
ings. PPG expression was detected in all 12 cells, thus
verifying their phenotype, but no cell tested positive for
GLP-1 receptor mRNA. By contrast, GLP-1 receptor mRNA
was detected successfully in a 1:1,000 dilution of mouse
brainstem cDNA (Fig. 4C).
Although these ﬁndings exclude a direct effect of GLP-1
on PPG cells, we also examined whether presynaptic
GLP-1 receptors might modulate synaptic inputs onto PPG
neurons. However, local application of 10 nmol/l exendin-4
had no signiﬁcant effect on either the amplitude or fre-
quency of sEPSCs (n 	 5; Fig. 4D and E).
In a further series of experiments, we examined the
effects of two more gut-derived peptides involved in
appetite control. PYY3–36 (100 nmol/l), which is co-re-
leased with GLP-1 from enteroendocrine L-cells, was with-
out effect on membrane properties and sEPSC frequency
or amplitude in voltage-clamp recordings (n 	 6; Fig. 4D
and E). In accordance with these results, no Y2 receptor
message was detected with single-cell RT-PCR analysis of
six PPG neurons. Ghrelin (100 nmol/l), which is released
from the stomach as an orexinergic signal, also failed to
elicit any signiﬁcant change in membrane potential, mem-
brane resistance, or spontaneous action potential ﬁring
rate in PPG cells (n 	 5; Fig. 4F).
Effects of leptin on PPG neurons. To investigate
whether the anorexigenic peptide leptin has direct effects
on PPG neuron activity, we tested its effect in perforated
patch current clamp recordings. Leptin (20 nmol/l) applied
locally caused a depolarization of 9  2 mV that was
accompanied by an increase in ﬁring frequency and a
decrease in membrane resistance in eight of eight PPG
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FIG. 1. Basic properties of PPG neurons of the NTS. A: Photomicrograph showing the location of PPG-Venus neurons (green ﬂuorescence) in
relation to the cholinergic (red ﬂuorescence) dorsal vagal nucleus (DMNX) and hypoglossal nucleus (HN) in a 30-m coronal brainstem slice at
position Bregma 7.75 mm. The central canal and the dorsal border of the brainstem are indicated by dotted lines. B: Horizontal brainstem slice
demonstrating the catecholaminergic cells (red ﬂuorescence signifying anti-TH immunoreactivity) and PPG cells (green ﬂuorescence) are two
completely distinct cell populations that occupy overlapping areas of the NTS. The dotted line indicates the midline. CC, central canal. Confocal
analysis of selected regions from these slices suggests that there is no direct contact between TH-positive and PPG cells (data not shown). C:
Individual PPG neurons were identiﬁed by Venus ﬂuorescence (top, patch pipette position indicated by dotted lines) and recordings were
established under DIC illumination (bottom). D: In the cell-attached conﬁguration while waiting for perforation, the ﬁring phenotype of the
neuron was observed: i, regular ﬁring; ii, silent; iii, burst ﬁring. E: Typical perforated-patch current-clamp recordings from regular ﬁring neuron
(i) and burst ﬁring cell (ii). The ﬂuctuations in membrane potential underlying the burst ﬁring behavior persisted in TTX. F: injection of a 40
pA current pulse for 200 ms elicited an A-type K
 current (arrow) upon termination of the pulse in all three cell types. (A high-quality digital
representation of this ﬁgure is available in the online issue.)
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of leptin.
DISCUSSION
Activation of PPG neurons in the NTS has been linked to
a reduction of food intake in a number of studies that
demonstrated c-Fos expression in these cells in response
to satiety signals such as gastric distension, consumption
of sweetened milk, or elevated leptin levels (6–8,21,22).
However, because of the inability to identify PPG neurons
in live tissue, nothing has been known about their electri-
cal properties, or the direct modulation of their activity.
Our results describe for the ﬁrst time the electrical prop-
erties of PPG neurons located in the caudal NTS and their
direct activation by leptin.
General properties. Under resting conditions, the major-
ity of PPG neurons in the NTS were spontaneously active,
ﬁring action potentials at a frequency of 2 Hz. In this
respect, they resemble the neighboring population of
paraventricular nucleus–projecting catecholaminergic
neurons that were also reported to be spontaneously
active (18). POMC neurons in the NTS, by contrast, receive
visceral afferent input but are electrically silent unless
stimulated (19). At present, we do not know how the level
of spontaneous activity of PPG neurons translates to their
release of GLP-1 from nerve terminals. Recent studies by
Wan et al. (23,24) investigating the effects of GLP-1 and
GLP-1 antagonists on dorsal vagal neurons using an equiv-
alent preparation in rat found no evidence of tonic GLP-1
release onto pancreas-projecting vagal motoneurons. This
might be taken as an indication that the resting activity of
the PPG neurons is not sufﬁcient to induce local release of
GLP-1, although whether there is any tonic release of
GLP-1 at the level of the hypothalamus remains unknown.
NTS PPG neurons display A-type K
 currents, a feature
that they share with other second-order NTS neurons such
as TH-positive cells (18) as well as vagal preganglionic
neurons of the adjacent dorsal vagal motor nucleus
(DMNX [25]). In accordance with the hypothalamic pro-
jection of PPG neurons, A-type K
 currents have been
described previously in NTS neurons projecting to the
paraventricular nucleus, but not those projecting to the
caudal ventrolateral medulla (26).
Most PPG neurons in the NTS were found to be second-
order neurons that receive strong glutamatergic synaptic
input from the solitary tract and express non-NMDA type
glutamate receptors (27). These excitatory inputs would
be predominantly from visceral vagal afferents, in line with
the ﬁnding that c-Fos is induced in GLP-1 neurons upon
gastric distension (6).
Lack of GLP-1 modulation of activity. Rises in periph-
eral GLP-1 have been linked to activation of neurons
located in the NTS. Our electrophysiological and expres-
sion data provide direct evidence that NTS PPG neurons
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exclude the possibility that they might respond to activa-
tion of presynaptic GLP-1 receptors, this seems unlikely to
be the case because we observed no effect of GLP-1 or
exendin-4 on ﬁring rate or spontaneous synaptic activity.
Thus, even if peripheral GLP-1 was able to cross the
blood-brain barrier, it seems unlikely that it would have a
local effect on the activity of PPG neurons. It remains
possible, however, that potential connections between
GLP-1–sensitive cells in the area postrema and PPG cells
in the NTS might have been lost in the slice preparation.
An alternative pathway by which peripheral GLP-1
might modulate PPG cell activity in the NTS is via GLP-1
receptors on vagal afferent neurons (14). GLP-1 receptor
mRNA has been detected in the inferior ganglion of the
afferent vagus (the nodose ganglion), and electrical activ-
ity in the vagus nerve was shown to respond to GLP-1
application (14). It is therefore possible that NTS PPG
cells, which appear to be predominantly second-order
neurons with regard to solitary tract stimulation, would
relay this vagal signal, resulting in central GLP-1 release in
the brainstem and hypothalamus. In support of this hy-
pothesis, it was shown that appetite suppression and
arcuate nucleus expression of c-Fos elicited by peripheral
GLP-1 were attenuated by vagotomy (28). The idea that
circulating GLP-1 is detected by peripheral rather than
central GLP-1 receptors was also suggested by the ﬁnding
that intraperitoneal but not intracerebroventricular appli-
cation of exendin (9–39) antagonized the appetite suppres-
sive effects of peripheral GLP-1 (29). However, direct
evidence that NTS PPG neurons are activated via a vagal
pathway when GLP-1 is released postprandially from
gastrointestinal L-cells is still lacking.
GLP-1 receptors have been reported on area postrema
neurons as well as in many other locations throughout the
brainstem (5,30). Electrophysiological studies in brain-
stem slices have demonstrated that pancreas-projecting
dorsal vagal neurons are both directly and indirectly
modulated by GLP-1 (23,24). The lack of GLP-1 respon-
siveness of PPG cells in the NTS suggests that PPG
FIG. 3. Stimulation of the solitary tract evokes glutamate EPSCs in PPG neurons. A: Voltage clamp recording from a PPG neuron in a horizontal
slice at a holding potential of 70 mV. Repetitive stimulation of the solitary tract (ﬁve pulses at 50 Hz every 20 s) evoked EPSCs of progressively
smaller amplitude, small failure rate, and low jitter (i.e., mono-synaptic) in most of these cells. A total of 10 consecutive traces are overlaid. B:
Some cells showed higher failure rates and larger jitter. A total of 10 consecutive traces are overlaid. C: All cells tested showed a marked
reduction in EPSC amplitude in the presence of glutamate receptor antagonists kynurenic acid (kyn) or DNQX (gray trace in i and ii). D: Mean
data from recordings as shown in C. **P < 0.01 against control. Numbers of cells tested (n) are given above the bars.
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pancreas-projecting dorsal vagal neurons. One possibility
is that they are actually the source of the GLP-1 that affects
vagal output.
Effects of other peripheral satiety and hunger pep-
tides on PPG cell activity. PYY3–36 is a satiety peptide
(31), released from intestinal L-cells in parallel with GLP-1.
Its peripheral administration has been shown to increase
c-Fos expression in cell bodies in the area postrema and
NTS, including populations that were negative for tyrosine
hydroxylase and might therefore overlap with PPG cells
(32). In brainstem slices, however, we were unable to elicit
either pre- or postsynaptic responses to PYY3–36 in NTS
PPG neurons. Peripheral injections of PYY3–36 and GLP-1
receptor agonists have synergistic effects on appetite
suppression in rats and mice (10). Destruction of vagal
afferent neurons using capsaicin prevented the reduction
of food intake by exendin-4, but not that by PYY3–36 (33),
suggesting that unlike GLP-1, the effect of PYY does not
require intact sensory neurons. Although the PYY3–36-
responsive receptor type, Y2, has been identiﬁed in a
number of brainstem regions including the area postrema
and NTS (34), it remains unclear whether the appetite
suppressive action of PYY3–36 depends on NTS PPG
neurons.
The adipocyte-derived hormone leptin directly and rap-
idly increased the electrical activity of PPG neurons. The
electrophysiological data suggest that this is mediated by
the activation of a depolarizing conductance, in contrast to
the inhibitory effect of leptin on K
 channels described
previously in ventromedial hypothalamic neurons (35).
These results provide a potential explanation for previous
ﬁndings that c-Fos immunoreactivity in PPG neurons is
induced by leptin exposure (7). They also support previ-
ous observations that PPG neurons in mice express leptin
receptor mRNA (9) and that leptin activates STAT3 phos-
FIG. 4. PPG neurons are not sensitive to gut peptides GLP-1 and PYY. A: Perforated patch clamp recording in current clamp demonstrating the
lack of effect of 100 nmol/l GLP-1 on PPG cell activity. The top trace shows the instantaneous ﬁring frequency over the course of the recording,
and the bottom traces show brief periods of the original recording at time points indicated by arrows. B: Mean ﬁring frequency in the absence
and presence of 100 nmol/l GLP-1 or 100 nmol/l of the GLP-1 receptor agonist exendin-4. C: Typical single-cell RT-PCR analysis for PPG and the
GLP-1 receptor (GLP-1R) for three PPG neurons and controls. The 2% agarose gel demonstrating that the 186-bp PCR product for PPG and
the 292-bp PCR product for GLP-1R can be obtained from brainstem cDNA (BS 1:1,000 dilution; positive control) with the primers speciﬁed in
Table 1. In contrast, cytoplasm extracted from single cells showing Venus ﬂuorescence (1–3) was only positive for PPG, but not GLP-1R. PIP,
pipette solution without cytoplasm extracted from cell (negative control). D: Neither exendin-4 nor the gut peptide PYY had any effect on
spontaneous EPSCs in PPG neurons. Left: Typical voltage-clamp recordings in the absence or presence of exendin-4. Right: Typical recordings
in the absence or presence of PYY. E: Mean data from recordings as shown in B for frequency and amplitude of spontaneous EPSCs. F: The peptide
ghrelin (100 nmol/l), released from stomach as orexinergic signal, had no effect on membrane potential (EM), input resistance (RM), or action
potential frequency. Numbers of cells tested (n) are given above the bars.
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neurons in mice, but not rats (21). The immediate effect of
leptin on PPG cell electrical activity suggests that a
component of the effect of this hormone, normally consid-
ered as a longer-term regulator of food intake, is mediated
by enhancing postprandial satiety signals involving NTS
PPG neurons. By contrast, the orexigenic peptide ghrelin
(36), which is released from the stomach in anticipation of
food ingestion, failed to affect the electrical activity of PPG
neurons. Thus, although ghrelin has been reported to
attenuate GLP-1–induced inhibition of food intake and
gastric emptying (11), our results suggest that this does
not happen at the level of the NTS PPG neurons.
In conclusion, our data provide a ﬁrst functional in vitro
characterization of PPG neurons in the caudal NTS—a
study made possible by the development of Venus-tagged
GLP-1 mice (15), which reliably express a ﬂuorescent
marker in PPG cells in the brainstem. Interestingly, we ﬁnd
that the activity of NTS PPG neurons is rapidly and
directly modulated by leptin but is unaffected by GLP-1,
PYY, or ghrelin. These ﬁndings have important implica-
tions for our understanding of the role of NTS PPG
neurons in relaying appetite signals between the periphery
and the hypothalamus.
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